Growth Metrics

Evolent Health (EVH) Accumulated Expenses (2016 - 2026)

Evolent Health has reported Accumulated Expenses over the past 11 years, most recently at $65.8 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 95.01% year-over-year to $65.8 million; the TTM value through Dec 2025 reached $65.8 million, up 95.01%, while the annual FY2025 figure was $65.8 million, 95.01% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $65.8 million at Evolent Health, up from $60.9 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $194.0 million in Q3 2023 and troughed at $19.4 million in Q1 2021.
  • A 5-year average of $65.6 million and a median of $45.1 million in 2021 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 494.36% in 2022 and later crashed 83.7% in 2024.
  • Year by year, Accumulated Expenses stood at $51.9 million in 2021, then soared by 114.42% to $111.2 million in 2022, then crashed by 49.29% to $56.4 million in 2023, then crashed by 40.2% to $33.7 million in 2024, then skyrocketed by 95.01% to $65.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for EVH at $65.8 million in Q4 2025, $60.9 million in Q3 2025, and $38.3 million in Q2 2025.